A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer's disease.

Qiliang HeKay M Colon-MotasAlyssa F PybusLydia PiendelJonna K SeppaMargaret L WalkerCecelia M ManzanaresDeqiang QiuSvjetlana MiocinovicLevi B WoodAllan I LeveyJames J LahAnnabelle C Singer

Published in: Alzheimer's & dementia (New York, N. Y.) (2021)

These findings show that prolonged gamma sensory flicker is safe, tolerable, and feasible with preliminary indications of immune and network effects, supporting further study of gamma stimulation in AD.

Keyphrases

clinical trial
study protocol
cognitive decline
phase iii
randomized controlled trial
mild cognitive impairment
open label